BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20860603)

  • 1. Requirement of phosphatase of regenerating liver-3 for the nucleolar localization of nucleolin during the progression of colorectal carcinoma.
    Semba S; Mizuuchi E; Yokozaki H
    Cancer Sci; 2010 Oct; 101(10):2254-61. PubMed ID: 20860603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression.
    Mizuuchi E; Semba S; Kodama Y; Yokozaki H
    Int J Cancer; 2009 Apr; 124(8):1802-10. PubMed ID: 19115206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
    J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
    Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
    Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells.
    Al-Aidaroos AQ; Yuen HF; Guo K; Zhang SD; Chung TH; Chng WJ; Zeng Q
    J Clin Invest; 2013 Aug; 123(8):3459-71. PubMed ID: 23867504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].
    Zhao GP; Zhou ZG; Lei WZ; Yu YY; Zheng XL; Gao HK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):237-40. PubMed ID: 16167237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-Regulation of Phosphatase in Regenerating Liver-3 (PRL-3) Contributes to Malignant Progression of Hepatocellular Carcinoma by Activating Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN)/Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway.
    Li BH; Wang Y; Wang CY; Zhao MJ; Deng T; Ren XQ
    Med Sci Monit; 2018 Nov; 24():8105-8114. PubMed ID: 30418964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous
    Sheikh TI; Harripaul R; Vasli N; Ghadami M; Santangelo SL; Ayub M; Sasanfar R; Vincent JB
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long noncoding RNA LUCAT1 promotes colorectal cancer cell proliferation by antagonizing Nucleolin to regulate MYC expression.
    Wu R; Li L; Bai Y; Yu B; Xie C; Wu H; Zhang Y; Huang L; Yan Y; Li X; Lin C
    Cell Death Dis; 2020 Oct; 11(10):908. PubMed ID: 33097685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma.
    Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Watanabe M
    Int J Cancer; 2010 Aug; 127(3):543-54. PubMed ID: 19960436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
    McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
    Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Snail as a key regulator of PRL-3 gene in colorectal cancer.
    Zheng P; Meng HM; Gao WZ; Chen L; Liu XH; Xiao ZQ; Liu YX; Sui HM; Zhou J; Liu YH; Li JM
    Cancer Biol Ther; 2011 Oct; 12(8):742-9. PubMed ID: 21811102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2.
    Min SH; Kim DM; Heo YS; Kim HM; Kim IC; Yoo OJ
    Life Sci; 2010 Jan; 86(1-2):66-72. PubMed ID: 19945467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRL phosphatases as potential molecular targets in cancer.
    Stephens BJ; Han H; Gokhale V; Von Hoff DD
    Mol Cancer Ther; 2005 Nov; 4(11):1653-61. PubMed ID: 16275986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRL-3 phosphatase is implicated in ovarian cancer growth.
    Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner.
    Xu H; Lai W; Zhang Y; Liu L; Luo X; Zeng Y; Wu H; Lan Q; Chu Z
    BMC Cancer; 2014 May; 14():330. PubMed ID: 24885636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRL-3 improves colorectal cancer cell proliferation and invasion through IL-8 mediated glycolysis metabolism.
    Xu H; Zeng Y; Liu L; Gao Q; Jin S; Lan Q; Lai W; Luo X; Wu H; Huang Y; Chu Z
    Int J Oncol; 2017 Oct; 51(4):1271-1279. PubMed ID: 28791350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.